Anzeige
Mehr »
Mittwoch, 02.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
255 Leser
Artikel bewerten:
(1)

Medical Device Analytical Testing Outsourcing Market to Surpass $10,905 Million Revenue by 2030, Says P&S Intelligence

NEW YORK, Oct. 17, 2022 /PRNewswire/ -- According to the latest market research study published by P&S Intelligence, the revenue of the medical device analytical testing outsourcing market was about $4,712 million in 2021, which will reach almost $10,905 million by 2030, at a growth rate of around 10%.

P&S Intelligence Logo

Cardiac Device Validation in Highest Demand

Cardiac medical device testing outsourcing is the most demanded, accounting for a value of about $1,312 million in 2021. The usage of cardiac devices is due to the rising incidence of CVDs, which already kill almost 18 million people each twelvemonth.

Moreover, the demand for general and plastic surgery device validation outsourcing will grow rapidly. The presence of professional outsourcing administrations meeting the supervisory criteria, along with the snowballing demand for aesthetic procedures, will help the industry grow.

In the future, the bioburden testing category will grow at a significant rate. Bioburden testing involves the quantification of the population of microbes on medical equipment. As per the international standards, the aim is to reduce bacterial contamination before sterilization.

Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/medical-device-analytical-testing-outsourcing-market/report-sample

Analytical Testing Widely Conducted for Reprocessed Devices

The reprocessed device category accounts for the higher revenue generation within the device type segment, and it will grow at the higher rate, of about 10%, in the future. Reprocessing is done for cutting expenditures, but it often risks the safety of patients.

Hospitals Are Largest Users of Analyzed & Tested Medical Devices

Hospitals are the industry leaders with an over 84% revenue share. This is because of the snowballing number of patients in hospitals and the increasing financial allocation by hospital administrations for these services.

Another factor responsible for the wide requirement for analytical testing for medical equipment in hospitals is their increasing need for advanced devices. These facilities have pioneering medical devices, which are requiring to be efficiently analyzed for performance.

  • APAC was the global dominator, with an over 39% revenue share, in the past, because of the measures of the local governments for improving their healthcare infrastructure. Furthermore, the economic expansion in India and China will help the industry boom.
  • Moreover, because of the huge population and low spending power the region, there is a high requirement for cheap treatments. Furthermore, MNCs are keen to invest in these emerging economies due to the availability of cost-effective labor.
  • The U.S. is the market leader, and its revenue contribution will grow at a rate of about 10%. This is because it is among the most-important manufacturing centers for reliable and cutting-edge medical products.

Browse detailed report on Global Medical Device Analytical Testing Outsourcing Market Size, Trends and Demand Forecast Report, 2030

The growth of the industry is essentially because of the increasing number of small-scale makers of medical devices, snowballing demand for medical device usefulness and safety confirmation and validation, existence of stringent regulations on medical device safety and efficacy, and increasing preference of key medical device producers for subcontracting analytical testing activities.

Medical Device Analytical Testing Outsourcing Market Report Coverage

By Services

  • Extractable & Leachable
  • Material Characterization
  • Physical Testing
  • Bioburden Testing
  • Sterility Testing

By Therapeutic area

  • Cardiology
  • Diagnostic Imagining
  • Orthopedic, IVD
  • Ophthalmic
  • General & Plastic Surgery
  • Drug Delivery
  • Endoscopy
  • Dental
  • Diabetes Care

By Device Type

  • Reprocessed Devices

By End Use

  • Hospital

Regional Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Browse More Reports Published by P&S

Pharmaceutical Analytical Testing Outsourcing Market- Global Industry Revenue Estimation and Demand Forecast to 2030

Clinical Trials Outsourcing Market- Global Industry Revenue Estimation and Demand Forecast to 2030

Medical Device Outsourcing Market- Global Industry Revenue Estimation and Trends Analysis

Computed Tomography Market Size and Share Analysis- Global Industry Revenue Estimation and Demand Forecast to 2030

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Follow Us: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medical-device-analytical-testing-outsourcing-market-to-surpass-10-905-million-revenue-by-2030--says-ps-intelligence-301650515.html

© 2022 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.